Treating trisomies: Prenatal Down's syndrome therapies explored in mice (original) (raw)
- News Feature
- Published: 06 January 2016
Nature Medicine volume 22, pages 6–7 (2016)Cite this article
- 2985 Accesses
- 12 Citations
- 15 Altmetric
- Metrics details
Subjects
Routine, noninvasive prenatal screening tests are allowing many women to learn early in the course of pregnancy whether their fetuses are affected by Down's syndrome, a condition that affects about 1 in 700 children born in the US. The prenatal screening results, which are confirmed with further diagnostic tests such as an amniocentesis, often lead pregnant women to question what they can do.
Right now, Bianchi and her colleagues have no prenatal treatments to offer these women. But they think that growing insights about how trisomy 21 shapes brain development have opened up the possibility of one day turning a prenatal diagnosis into an opportunity for treatment. Studies in mice with a Down's syndrome–like condition have already shown that prenatal treatments can improve learning and memory, although substantial hurdles remain.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
The Role of Oxidative Stress in Trisomy 21 Phenotype
- Angelika Buczyńska
- , Iwona Sidorkiewicz
- … Monika Zbucka-Krętowska
Cellular and Molecular Neurobiology Open Access 11 October 2023
Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer’s-like memory deficits in the Ts65Dn mouse model of Down syndrome
- Syed Faraz Kazim
- , Julie Blanchard
- … Khalid Iqbal
Scientific Reports Open Access 03 April 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
References
- Larsen, K.B. Ann. Anat. 109, 421–427 (2008).
Article Google Scholar - Bahado-Singh, R.O. et al. Am. J. Obstet. Gynecol. 167, 1009–14 (1992).
Article CAS Google Scholar - Reeves, R.H. et al. Nat. Genet. 11, 177–184 (1995).
Article CAS Google Scholar - Gardiner, K.J. Drug Des. Devel. Ther. 9, 103–125 (2015).
CAS PubMed Google Scholar - Belichenko, P.V. et al. Comp. Neurol. 480, 281–298 (2004).
Article Google Scholar - Bartesaghi, R. et al. J. Neurosci. 35, 13843–13852 (2015).
Article Google Scholar - Guidi, S. et al. Brain 137, 380–401 (2014).
Article Google Scholar - Malberg, J.E., Eisch, A.J., Nestler, E.J. & Duman, R.S. J. Neurosci. 20, 9104–9110 (2000).
Article CAS Google Scholar - Reefhuis, J., Devine, O., Friedman, J.M., Louik, C. & Honein, M.A. B.M.J. 351, h3190 (2015).
Article Google Scholar - Bianchi, D. Nat. Med. 18, 1041–1051 (2012).
Article CAS Google Scholar - Moon, J. et al. Behav. Neurosci. 124, 346–361 (2010).
Article CAS Google Scholar - De La Torre, R. et al. Mol. Nutr. Food Res. 58, 278–288 (2014).
Article Google Scholar
Author information
Authors and Affiliations
- Bridget M. Kuehn is a Chicago-based freelance writer specializing in biomedicine.,
Bridget M. Kuehn
Rights and permissions
About this article
Cite this article
Kuehn, B. Treating trisomies: Prenatal Down's syndrome therapies explored in mice.Nat Med 22, 6–7 (2016). https://doi.org/10.1038/nm0116-6
- Published: 06 January 2016
- Issue date: January 2016
- DOI: https://doi.org/10.1038/nm0116-6
This article is cited by
The Role of Oxidative Stress in Trisomy 21 Phenotype
- Angelika Buczyńska
- Iwona Sidorkiewicz
- Monika Zbucka-Krętowska
Cellular and Molecular Neurobiology (2023)
Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer’s-like memory deficits in the Ts65Dn mouse model of Down syndrome
- Syed Faraz Kazim
- Julie Blanchard
- Khalid Iqbal
Scientific Reports (2017)
Mouse models of Down syndrome: gene content and consequences
- Meenal Gupta
- A. Ranjitha Dhanasekaran
- Katheleen J. Gardiner
Mammalian Genome (2016)